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lcohol is a common “addictive”substance.As a
psychoactive compound,it can elicit a spectrum of behav-
ioral effects,which include gregariousness,aggression,loss
of executive function,and cognitive deficits.While phar-
macokinetic factors (absorption,distribution in the tissues,
and rate of metabolism,primarily in the liver) contribute
to the intensity and duration of ethanol’s actions, the
behavioral manifestations are a consequence of the effects
of ethanol on the brain.The spectrum of behavioral effects
is attributed to the ability of ethanol to inhibit or activate
multiple neural pathways,and how one responds to alco-
hol will ultimately depend on how the neural pathways are
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Alcohol dependence (alcoholism) is a complex disorder attributed to the interaction of genetic and environmental fac-
tors that form a collage of “disease” predisposition, which is not identical for every alcohol-dependent individual.
There is considerable evidence to demonstrate that genetic predisposition accounts for roughly half the risk in the
development of alcohol dependence. Both family and population studies have identified a number of genomic regions
with suggestive links to alcoholism, yet there have been relatively few definitive findings with regard to genetic deter-
minants of alcoholism. This ambiguity can be attributed to a multitude of complications of studying complex mental
disorders, such as clinical heterogeneity, polygenic determinants, reduced penetrance, and epistatic effects. Complex
mental disorders are clinical manifestations described by combinations of various signs and symptoms. One approach
to overcoming the ambiguity in studying the association between genetic risk factors and disease is to dissect the com-
plex, heterogeneous disorder by using intermediate phenotypes—or endophenotypes—to generate more homoge-
neous diagnostic groupings than an all-encompassing definition, such as the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV)–derived term “alcohol dependence” or the commonly used term “alco-
holism.” The advantage of using endophenotypes is that the number of influential factors that contribute to these
characteristics should be fewer and more easily identified than the number of factors affecting the heterogeneous
entity of alcohol dependence (alcoholism). A variety of alcohol-related characteristics have been investigated in epi-
demiological, clinical, and basic research as potential endophenotypes of alcohol dependence. These include pheno-
types related to alcohol metabolism, physiological and endocrine measures, neural imaging, electrophysiology, per-
sonality, drinking behavior, and responses to alcohol and alcohol-derived cues. This review summarizes the current
literature, focused on human data, of promising endophenotypes for dissecting alcoholism.  
© 2005, LLS SAS Dialogues Clin Neurosci. 2005;7:153-163.organized in an individual,and the extent to which certain
pathways are inhibited or activated.It is known that there
is substantial variability in the response to alcohol,and dif-
ferences in cognitive evaluation of ethanol’s effects are
likely to play a significant role in the predisposition to alco-
hol abuse and dependence.
Although the diagnoses for alcohol use disorders are
based on a range of reported symptoms,they are typically
treated as a binary outcome (affected or unaffected).As
early as the 1960s,it was conceptualized that alcoholism
was not a single entity and that various types of alco-
holism existed.Jellinick originally identified five “species”
of alcoholism characterized by psychological and physi-
ological dependence.
1 Researchers have utilized and
refined such typological schemes in order to identify
more etiologically homogeneous subtypes as a means for
studying,diagnosing,and treating alcoholism.
2-4
As with all complex diseases,alcoholism can be thought
of as a clinical outcome that has been generated by a
combination of many risk factors,and the alcohol-depen-
dent population represents a spectrum of individuals dis-
playing different sets of symptoms and severity of dis-
ease.Genetic factors that affect susceptibility to alcohol
dependence may be involved in only certain components
of the spectrum of alcohol dependence,such as alcohol
metabolism,personality,cognitive function,and neuro-
physiology.
5An approach for identifying alcohol suscep-
tibility genes is to focus on the particular components of
the dependence spectrum,ie,intermediate phenotypes
that influence susceptibility to alcohol dependence,also
known as endophenotypes.With reference to genetic the-
ories in schizophrenia research,Gottesman and Shields
6
originally defined endophenotypes as internal pheno-
types,not obvious to the unaided eye,which can fill the
gap between the gene and the available descriptors of
disease.More recently,Tsuang et al
7 established the fol-
lowing criteria for evaluating endophenotypes
8:
• Specificity.The endophenotype is more strongly asso-
ciated with the disease of interest relative to other psy-
chiatric conditions.
• State-independence.The endophenotype is stable over
time and not merely indicative of the disease process
or its treatment.
• Heritability.Variance in the endophenotype is associ-
ated with genetic variance.
• Familial association.It is more prevalent among the rel-
atives of ill probands compared with the appropriate
control group.
• Cosegregation.The endophenotype is more prevalent
among the affected relatives compared with the unaf-
fected relatives of affected probands.
• Biological and clinical plausibility.The endophenotype
bears some conceptual relationship to the disease.
The advantage of using endophenotypes is that the num-
ber of genetic and environmental factors that contribute
to these should be easier to identify because the number
of factors influencing each is fewer than the number
affecting the undifferentiated clinical syndrome.
9
Endophenotypes have been utilized extensively when
nonhuman animals have been used to study alcohol
use–related phenomenon.Animal models have proven
to be an ideal tool for identifying genetic and environ-
mental factors that influence alcohol-related traits due to
the ability to conduct studies under controlled environ-
mental and genetic conditions. Furthermore, animal
models provide an opportunity to assess quite specific
alcohol-related endophenotypes,such as alcohol prefer-
ence,sensitivity,tolerance,and dependence.For example,
selected lines of mice produced from breeding animals
for certain endophenotypes have been widely used in
mapping quantitative trait loci (QTL), an analytical
method utilized to identify regions of the genome influ-
encing a specific trait by comparing genetic markers that
are shared by lines or strains displaying extremes in
quantitative endophenotypes.Several selected lines that
differ with respect to various alcohol-related traits have
been developed to identify genetic differences con-
tributing to differences in the effects of alcohol.This area
of research has recently been reviewed.
10
Although animal models provide for “proof of concept,”
which indicates that the definition and utilization of
endophenotypes can lead to a better understanding of
the etiology of the endophenotype and provide a means
for identifying which genetic factors would be of interest
to study in humans,not all observations in the nonhuman
animal are necessarily applicable to humans.Thus,it is
essential to conduct studies with human populations in
order to elucidate the pathophysiology of human disease.
Recent research efforts with humans have focused on the
identification and incorporation of endophenotypes to
study risk factors for alcoholism.Schuckit recently pro-
posed that the majority of genetically related markers of
alcoholism risk were represented by five relatively inde-
pendent overarching categories (endophenotypes),which
include level of response,neuronal or behavioral disin-
hibition,independent axis I major psychiatric disorders,
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11
A variety of additional traits have been investigated in
epidemiological research as potential endophenotypes
for alcohol dependence.These include endophenotypes
related to endocrine measures, electrophysiology, per-
sonality,and drinking behavior.
Behavioral and physiological traits
Low alcohol response
Researchers have investigated the significance of sensi-
tivity to intoxication with respect to the development of
alcohol dependence.
12-15 Low response to alcohol is a well-
characterized biological measure,which is indicative of
alcohol sensitivity,specifically the need for more alcohol
to produce an effect.
11 It has been hypothesized that low
response increases the risk of alcohol dependence by
increasing the probability of heavy drinking and acquisi-
tion of tolerance and dependence.
11
Historically, level of response (ie, a low response) has
been assessed through various measurements, which
include level of change in subjective feelings of intoxica-
tion, motor performance, hormone levels, and/or elec-
trophysiological measures observed at specific blood
alcohol concentrations,or by a self-report of the number
of drinks required for specific effects.
16-18The effects of
ethanol can be measured by the use of the alcohol chal-
lenge test,where subjects are typically given three to five
standard drinks to be consumed over approximately 10
minutes.
13,14,16
A low response has been found to be a predictor of
future alcohol use disorders among various populations,
including Native Americans and Koreans.
19,20 However,
contradictory results have been observed in other stud-
ies.These inconsistencies have been attributed to differ-
ing methods of alcohol administration and limited sam-
ple size.
21-23An estimated 40% of offspring of alcoholics
have a low response to alcohol,and prospective studies
have shown that it may be a predictor of future devel-
opment of alcohol use disorders among alcoholic off-
spring.
24-26 Both animal and human twin studies have
found that response is genetically influenced.
15 Genetic
factors are estimated to account for 60% of the variance
in response to alcohol.
12,27 Among certain populations,
low response could explain up to 50% of the relation-
ship between family history of alcohol use disorders and
risk of alcoholism.
11 In a recent review, data from vari-
ous animal and human studies were summarized and
various candidate genes involved were implicated in
influencing level of response to alcohol.
15These include
genes related to the second-messenger system (adenylyl
cyclase [AC]/cyclic adenosine-3´,5´-monophosphate
[cAMP] system), neurotransmitters (endogenous opi-
oids,serotonin,γ-aminobutyric acid [GABA],adenosine,
dopamine), and alcohol metabolism (alcohol dehydro-
genase, catalase, cytochrome P450 enzyme CYP 2E1).
For example,a recent study by Ray and Hutchison
28 has
found an association between the A118G single
nucleotide polymorphism (SNP) of the µ-opioid recep-
tor gene and sensitivity to the effects of alcohol.
Specifically, individuals with at least one copy of the G
allele, which codes for the more potent µ-opioid recep-
tors,displayed higher sensitivity to the stimulatory,seda-
tive, mood-altering, and subjective feelings of intoxica-
tion.
28 Furthermore, previous studies have implicated a
polymorphism in the promoter region of the serotonin
transporter gene (5´HTLPR, locus ID SLC6A4) with
subjective feelings of intoxication during an alcohol chal-
lenge protocol using a nonclinical sample.
29 Taken
together, these studies underscore the importance of
evaluating individual differences in alcohol sensitivity,
particularly with regard to the quality of the alcohol
intoxication, as a potential endophenotype for alcohol
use disorders.Some of the strengths of this endopheno-
type include its specificity, state-independence, heri-
tability, and biological and clinical plausibility. Further
information is needed regarding familial association and
cosegregation applied to alcohol response endopheno-
type.
Alcohol metabolism
The Australian Alcohol Challenge Twin Study,initiated
over 20 years ago,has provided substantial contributions
to understanding the genetics of alcohol metabolism in
relation to alcohol use disorders,such as heritability of
various alcohol-related traits including alcohol con-
sumption habits and pharmacokinetic measures.
30,31 Initial
studies have demonstrated genetic influences on peak
blood alcohol concentrations,rate of decrease in blood
alcohol concentration,and alcohol dependence.
32 More
recently, Whitfield et al analyzed the relationship
between blood or breath alcohol values after an alcohol
challenge test,a reflection of pharmacokinetics,and risk
of alcohol dependence over a 10-year period of follow-
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33They observed a two- to threefold increased risk in
individuals who demonstrated blood or breath alcohol
concentrations in the highest quartile of values compared
with those in the lowest.
Genetic variation among alcohol-metabolizing genes has
been well studied with respect to their role in affecting
predisposition to alcohol dependence.
34A functional vari-
ant in aldehyde dehydrogenase type 2 (ALDH2), pre-
dominantly observed among Asian populations,produces
a reduced capacity to metabolize acetaldehyde and a
physiologic flushing response and is believed to con-
tribute to the aversion to alcohol consumption.
35 Genetic
variants among the class I alcohol dehydrogenases have
also been implicated in modulating levels of alcohol
intake.
35These findings suggest that alcohol metabolism
does influence susceptibility to alcohol use disorders.
Prospective studies have been pursued to evaluate the
role of variation in alcohol metabolism on risk of alcohol
dependence.
13,33 Overall,there is evidence suggesting that
genes that affect alcohol pharmacokinetics are likely to
contribute to the levels of alcohol consumption by indi-
viduals.
Electrophysiological measures
Various electrophysiological measures of the brain have
been implicated in predisposition to alcohol use disorders.
Evidence from twin studies suggests that a substantial
proportion of the variance in electroencephalographic
(EEG) patterns is genetically determined.
36-39 Studies
investigating the EEG of chronic alcoholics have reported
the alcoholic EEG to be of lower voltage,to be deficient
in α activity,to be higher in β activity,to contain some θ
activity,and to have an excess of fast activity.
19,40-44 Studies
conducted on offspring of alcoholic fathers suggest that
certain EEG variants may be potential endophenotypes
for development of alcohol dependence.
19,45
A biological trait that has received considerable atten-
tion is the P300 waveform,also known as P3,of the event-
related brain potential (ERP).The P3 waveform repre-
sents the largest positive peak voltage of the
event-related potential occurring between 250 and 500
ms after presentation of a stimulus.
46This component is
believed to depict several aspects of cognitive function,
including attention and maintenance of working mem-
ory.
47 It has been suggested that diminished P3 ampli-
tudes or shorter latencies reflect problems in attending
and interpreting subtle environmental events.
48,49
Research has shown that alcoholic individuals also have
reduced P3 amplitude and that offspring of alcoholics
with low P3 amplitude are more likely to develop an
alcohol use disorder.
50
A low-voltage α resting EEG trait has also been previ-
ously associated with alcoholism and anxiety disorders.
51
Alpha (8-13 Hz) represents the EEG waveform that pre-
dominates in an individual who is awake and alert,while
relaxed.
51Typically,α oscillations will greatly diminish or
disappear during periods of high arousal.Individuals with
the low-voltage α resting EEG trait appear to have an
atypical EEG characterized by few or no α oscillations,
resembling an EEG of increased arousal.Alcoholics tend
to have low-amplitude α.
52 However,high-voltage α has
also been suggested as a potential risk factor for alcohol
dependence.In two different studies,men with alcoholic
fathers were more likely to have high-voltage α than men
with no alcoholic relatives.
53-55This finding has also been
observed in a sample of women at high risk for alco-
holism.
56Taken together,these studies suggest that sub-
jects at high risk for the development of alcoholism may
be characterized by an atypical variation of α.
Various other attributes of EEG have also been impli-
cated.In one study,young children (11 to 13 years old)
of alcoholic parents were found to have more relative
fast (β,>18 Hz) activity in their EEG than children with-
out alcoholic parents.
57 In a recent study examining older
adults with alcoholic relatives, sons of alcoholics were
found to have elevated β amplitudes in specific regions
of the brain
58;however,other studies have not observed
this finding.
42,59 Both linkage and candidate gene analysis
that incorporate various aspects of EEG are currently
being explored in connection with certain subtypes
(endophenotypes) of alcohol dependence.
Alcohol craving
Alcohol craving has been defined as a strong desire to
consume alcohol and has been associated with loss of con-
trol over drinking,which is part of the alcohol dependence
syndrome, as defined in the Diagnostic and Statistical
Manual of Mental Disorders,Fourth Edition (DSM-IV).
Although there has been some controversy over the def-
inition and use of the term,the endophenotype of craving
is a construct that is central to alcohol dependence and is
often a target of intervention effort.
60-63Although there has
been controversy over the measurement of subjective
“craving”in humans,craving and loss of control drinking
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the mesolimbic and mesocortical dopamine pathways in
the brain (the neural substrates that putatively underlie
the attribution of incentive salience to alcohol and other
drugs of abuse),which is thought to be an important fac-
tor in the etiology of alcohol dependence.Individual dif-
ferences in the development of loss of control drinking
and the ability to stop drinking are likely to be related to
genetic factors that influence the effects of alcohol on
mesolimbic dopamine activation and craving.
A few studies have investigated the pharmacological and
genetic underpinnings of craving for alcohol.For exam-
ple,a study by Hutchison et al
64 has found that individu-
als with the “long”variant (7 or longer repeat allele) of
the D4 dopamine receptor gene (DRD4 VNTR) dis-
played higher craving after consumption of alcohol,as
compared with the placebo beverage.In addition,a phar-
macological trial of olanzapine in a nonclinical sample
found that individuals with the long allele of the DRD4
VNTR demonstrated greater reduction in craving after
alcohol consumption during the medication condition,as
compared with individuals with the short allele.
65These
results were later expanded using a clinical sample, in
which patients with the long allele of the DRD4 VNTR
experienced greater reductions in craving for alcohol and
reduced alcohol consumption during the course of treat-
ment,as compared with individuals with the short allele.
66
The fact that craving has been linked to specific biolog-
ical mechanisms and has both etiological and clinical
implications demonstrates its utility as an endophenotype
for studying genetic and pharmacological factors associ-
ated with alcoholism and its treatment.
Neuroimaging-derived endophenotypes
Advances in imaging technology have provided the field
with an opportunity to refine and expand the conceptu-
alization of phenotypes that lend themselves to the iden-
tification of genetic variations that influence the etiology
of alcohol and drug dependence.For example,there have
been a number of studies that have utilized functional
magnetic resonance imaging (fMRI) technology to inves-
tigate craving for alcohol by examining the hemodynamic
response of brain structures after exposure to alcohol
cues.
67-69 Specifically, one study has found that alcohol-
related stimuli increased activation in the prefrontal cor-
tex and anterior thalamus,
67 whereas another study noted
activation in the prefrontal cortex and anterior limbic
areas.
68 Furthermore,a study utilizing alcohol odor as an
alcohol cue found significant increases in activation of
the cerebellum and amygdala in alcoholics,but not con-
trols.
69 These differences, however, were not observed
after treatment and no evidence of a correlation between
brain activation and subjective craving was presented.
Imaging techniques provide the opportunity to examine
endophenotypes that are more proximal to the biologi-
cal mechanisms that underlie risk for the development of
alcohol use disorders.For example,the interplay of the
mesocortical and mesolimbic structures represents a
potential endophenotype for alcoholism,given that these
structures are putatively associated with alcohol craving.
An important advantage of the neuroimaging approach
is the fact that the output does not rely on subjective
reports of effect,which can induce a great deal of exper-
imental variability.Measuring a more biologically based
expression of the incentive salience of alcohol provides
an objective means of defining the endophenotype.
Major psychiatric disorders
Psychiatric disorders,such as mood disorders and anxi-
ety,are common comorbidities of alcoholism.
70An esti-
mated two-thirds of people with antisocial personality
disorder are alcohol-dependent.
11 Depending on the indi-
vidual,psychiatric symptoms may be manifestations of
intoxication and withdrawal, or be precursors for the
development of alcohol abuse.
71,72 Diagnoses of psychi-
atric disorders,as well as alcohol dependence,are based
on a range of symptoms,which potentially reflect distinct
etiologies.There is substantial evidence indicating that
most psychiatric disorders,similar to alcohol dependence,
are complex disorders that have a substantial genetic
component.It is likely that certain genetic components
involved in the susceptibility to psychiatric disorders are
also likely to contribute to the development of alco-
holism.A prospective study of 11-year-old children found
three traits related to different dimensions on a person-
ality questionnaire—specifically high novelty-seeking,
harm avoidance,and reward dependence—were predic-
tive of later alcohol abuse.
73 Furthermore,certain genetic
variants have been found to be associated with alco-
holism as well as certain psychiatric disorders.
52,74 Several
studies of the genetics of psychopathology have identi-
fied common genes that may be associated with a variety
of disordered behaviors.For example,the D4 dopamine
receptor gene has been linked to attention deficit–hyper-
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activity disorder (ADHD), schizophrenia, and alcohol
craving.
64 Likewise, a polymorphism of the promoter
region of the serotonin transporter gene (5´HTLPR,
locus ID SLC6A4) has been associated with alcohol
dependence,
75,76 suicide attempts,
77 anxiety symptoms,
78
and major depressive disorder.
79These results however,
are mixed, and several negative findings question the
replicability of the positive findings.
Such investigations however, raise an important issue
regarding the specificity of endophenotypes for alco-
holism,given that a series of common genes may be asso-
ciated with a host of psychopathological behaviors.It is
possible that common factors may confer risk for several
psychopathologies.For instance,personality factors,such
as impulsivity and sensation/novelty-seeking,may also
represent a common index of vulnerability to various
psychopathologies.The hypothesis that common factors
may confer risk or protection to more than one form of
psychopathology led investigators to refine the endophe-
notypes such that they become better defined and possi-
bly more psychopathology-specific.However,one should
not cling thoughtlessly to current mental disease classifi-
cations when data regarding endophenotypes may be
suggesting new relationships between causal factors and
disease manifestations.
Biochemical traits
Monoamine oxidase
Monoamine oxidase (MAO) catalyzes the oxidative
deamination of a number of neurotransmitters in the
brain and peripheral tissues.
80,81Two MAO enzymes,type
A and B,were discovered and characterized on the basis
of their substrate selectivity and inhibitor sensitivity.
82,83
The biochemistry and molecular biology of MAO have
been studied extensively.
80The finding of MAO activity
differences in platelets of alcohol-dependent individuals
versus controls was first reported approximately 40 years
ago.
84 It was subsequently found that human platelets
contained exclusively the B-type of MAO.
85 Early stud-
ies also suggested that low platelet MAO activity was
associated with certain personality traits,such as impul-
siveness, risk-taking behaviors, aggressiveness, and, in
particular, predisposition to alcohol and drug depen-
dence.
80,86 It has been hypothesized that low levels of
platelet MAO activity may be an endophenotype for pre-
disposition to alcohol and drug abuse; however, the
results from several studies have not been consistent,and
this discrepancy has been primarily attributed to the con-
founding effect of tobacco use.
80,86 Snell et al
87 examined
the relationship between differences in platelet MAOB
activity associated with alcohol dependence, cigarette
smoking,and gender.The findings suggested that lower
platelet MAO activity is attributed to cigarette smoking
and may reflect reduced substrate accessibility to the
MAO catalytic site in smokers. Prospective studies on
platelet MAO activity are necessary to further evaluate
its validity as an endophenotype for alcoholism.
Adenylyl cyclase
The enzymatic activity of AC has been proposed as a
potential endophenotype for alcohol dependence.AC is
responsible for the conversion of adenosine 5´-triphos-
phate (ATP) to the second messenger cAMP.
88,89 Other
major components involved in AC/cAMP pathway are
various extracellular signal receptors and heterotrimeric
guanine nucleotide-binding regulatory proteins (G pro-
teins) that couple the signals generated at receptors to
the catalysis of cAMP formation.Nine isoforms of the
mammalian AC enzyme (types I – IX),with differing reg-
ulatory properties,are known to exist.
88,90
AC activity is regulated by different receptors,including
dopamine,opiate,adenosine,muscarinic cholinergic,cor-
ticotropin-releasing factor (CRF) adrenergic,and sero-
tonergic receptors.These receptors interact with either
stimulatory (Gs) or inhibitory (Gi) G protein subtypes,
resulting in stimulation or inhibition of AC.
89 On the
other side of the cAMP signaling cascade, phosphodi-
esterases can inactivate cAMP through hydrolysis into
AMP.There are two known targets of cAMP in mam-
mals,the cAMP-dependent protein kinase (PKA) and
the cAMP-gated ion channel (predominantly found in
the olfactory neurons). The production of cAMP
depresses the activity of PKA, which then modulates
intracellular metabolism,receptor,or ion channel func-
tion,and gene expression in various cells and tissues.
88,90,91
cAMP-responsive binding element (CREB) is one exam-
ple of a transcription factor that can be modulated in its
function by the cAMP signaling cascade.
Many drugs,hormones,and neurotransmitters produce
their physiological effects by stimulating or inhibiting the
catalytic activity of AC, and thus affecting the concen-
tration of cAMP within the cell.
92AC activity in animal
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chronic ethanol treatment.
93AC activity can be measured
in both platelets and lymphocytes,although the results
can differ depending on which in vitro model is used.
11
Lower cAMP production following chemical stimulation
of platelets or white blood cells has been observed
among alcoholics and individuals with a family history of
alcoholism.
94 The production of cAMP in chemically
stimulated cells has been investigated in children of alco-
holics who might share lower levels of Gs protein–stim-
ulated cAMP production with their alcoholic relatives.
The children of alcoholic parents were found to have
lower platelet AC activity in comparison to children of
nonalcoholic parents.
95The risk of alcoholism could be a
result of low innate activity of AC, with acute alcohol
causing a temporary stimulation and subsequent absti-
nence producing the opposite effect.Thus,this might pro-
mote more alcohol intake in attempt to compensate for
low AC activity in individuals predisposed to alcohol
dependence or already dependent individuals.
95-97
As already mentioned,several studies have shown that
AC activity in platelets or lymphocytes of alcohol-depen-
dent individuals is less responsive to various stimulations,
such as that by forskolin, compared to non–alcohol-
dependent individuals.
98-103 However,it is not completely
clear if these differences are a consequence of alcohol
drinking or an indicator of susceptibility to alcohol
dependence.Recent studies have shown that platelet AC
activity decreases after a period of abstinence from heavy
drinking.
104 Furthermore,AC activity in alcohol-depen-
dent subjects was lower for those who abstained for a
period of time prior to testing.
104Various alcohol-related
factors that affect AC activity level may compromise its
utility as an endophenotype to study predisposition to
alcohol dependence.
104
β-Endorphins
The endogenous opioids,which include β-endorphins,are
proteins that bind to the opioid receptors. Alcohol is
believed to stimulate the release of certain opioid pep-
tides, which could interact with opioid receptors in
regions of the brain associated with reward and positive
reinforcement.
105 Increased activity of brain β-endorphin
(enkephalin) opioid peptide systems may be important
for initiating and maintaining high levels of alcohol con-
sumption.
105 Subjects with a family history of alcoholism
presented with lower concentrations of plasma β-enodor-
phin in the early morning hours and a more pronounced
increase in pituitary β-endorphin release after ingestion
of moderate doses of alcohol.
106,107When examining the
heritability of hormonal responses, a twin study found
that β-endorphin response to alcohol was heritable.
108
Decreased β-endorphin has been noted in the cere-
brospinal fluid (CSF) of abstinent alcoholics.
109 Opioid
antagonists, such as naltrexone, have been shown to
decrease the self-administration of alcohol in animals and
humans.
110-112This effect has been attributed to blunting
the stimulatory effect of alcohol,enhancing the sedative
effect, and/or decreased levels of reinforcement from
alcohol.
Conclusions
The use of the current DSM-IV classification for alcohol
use disorders has proven impractical in the pursuit of
identifying predisposing genetic and environmental risk
factors for the complex phenotype of dependence on
alcohol. This can be attributed to the fact that many
researchers have used DSM-IV criteria to arrive at
binary classifications based on a range of symptoms and,
thus,do not capture the heterogeneity of the disorder.
The ability to study well the multiple factors that con-
tribute to the development of “alcoholism”will depend
on the creation of more homogeneous subgroups by use
of endophenotypes.This can be achieved through the
development of new classification schemes based on
genetic/biological, physiological, and behavioral
endophenotypes.Future research in the area of alcohol
use disorders will continue to improve phenotypic defi-
nitions and ultimately contribute to the disentanglement
and elucidation of the etiology of the various compo-
nents that contribute to the multifaceted and complex
syndromes currently encompassed by the DSM-IV,the
International Classification of Mental and Behavioral
Disorders (ICD-10), and the lay public perceptions of
alcohol use disorders. ❏
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Alcoholismo: la disección mediante endofenotipos
La dependencia de alcohol (alcoholismo) es un trastorno complejo que se atribuye a la interacción de fac-
tores genéticos y ambientales que forman un collage para la  predisposición a la “enfermedad,” lo que no
es idéntico para cada individuo dependiente de alcohol. Existe una considerable evidencia que demuestra
que la predisposición genética da cuenta aproximadamente de la mitad del riesgo para el desarrollo de la
dependencia de alcohol. Tanto los estudios en familias como en población han identificado un número de
regiones del genoma que sugieren asociaciones con el alcoholismo, pero han sido relativamente pocos los
hallazgos definitivos en relación con determinantes genéticos del alcoholismo. Esta ambigüedad puede
atribuirse a diversas complicaciones del estudio de los trastornos mentales complejos, tales como la hete-
rogeneidad clínica, los determinantes poligénicos, la reducción de la penetración y los efectos epistáti-
cos. Los trastornos mentales complejos son manifestaciones clínicas descritas por combinaciones de varios
signos y síntomas. Una aproximación para superar la ambigüedad en el estudio de la asociación entre los
factores de riesgo genético y la enfermedad es disecar el trastorno heterogéneo y complejo mediante el
empleo de fenotipos intermediarios –o endofenotipos– para generar agrupaciones diagnósticas más homo-
géneas que la definición ampliamente abarcadora del término “dependencia de alcohol” derivada del
Manual Diagnóstico y Estadístico de los Trastornos Mentales, en su cuarta edición (DSM IV) o del término
“alcoholismo” utilizado comúnmente. La ventaja de utilizar endofenotipos es que el número de factores
que pueden ser determinantes en la contribución a estas características debe ser menor y de más fácil iden-
tificación que el número de factores que afectan la heterogénea entidad de la dependencia de alcohol
(alcoholismo). A través de estudios epidemiológicos, clínicos y básicos se ha investigado una variedad de
características relacionadas con el alcohol como potenciales endofenotipos de la dependencia de alcohol.
Estos incluyen fenotipos relacionados con el metabolismo del alcohol, mediciones fisiológicas y endocrinas,
neuroimágenes, electrofisiología, personalidad, conducta para beber y respuestas para señales para el alco-
hol y derivadas del alcohol. Esta revisión, focalizada en resultados en seres humanos, resume la literatura
actual de prometedores endofenotipos que permitan hacer una disección del alcoholismo. 
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Alcoolisme : le découpage des endophénotypes
La dépendance alcoolique (alcoolisme) est un trouble complexe attribué à l’interaction de facteurs géné-
tiques et environnementaux qui forment un ensemble de prédispositions à la " maladie " différentes pour
chaque individu alcoolodépendant. Il existe des arguments solides pour démontrer que les prédispositions
génétiques participent pour à peu près la moitié du risque dans le développement de la dépendance alco-
olique. Des études de population et familiales ont identifié un certain nombre de régions du génome pré-
sentant des liens évocateurs avec l’alcoolisme ; il y a eu jusqu’à maintenant relativement peu de résultats
définitifs en ce qui concerne les déterminants génétiques de l’alcoolisme. Cette ambiguïté peut être attri-
buée à une multitude de complications dans l’étude des troubles mentaux complexes, tels que l’hétéro-
généité clinique, les déterminants polygéniques, la pénétrance réduite et les effets épistatiques. Les trou-
bles mentaux complexes se manifestent cliniquement par des associations de signes et symptômes variés.
Découper ces troubles complexes, hétérogènes en utilisant des phénotypes intermédiaires – ou endophé-
notypes – pour former des groupes de diagnostic plus homogènes qu’une définition globale, telle que celle
de " dépendance alcoolique " ou celle courante d’ " alcoolisme " du DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) peut permettre de surmonter l’ambiguité qui existe dans l’é-
tude de l’association des facteurs de risque génétiques et la maladie. L’avantage des endophénotypes est
que le nombre de facteurs influents qui les caractérisent devrait être moins important et plus facilement
identifiable que le nombre des facteurs affectant l’entité hétérogène de la dépendance alcoolique (alco-
olisme). Nous avons recherché de multiples caractéristiques liées à l’alcool aux niveaux standard, clinique
et épidémiologique, comme endophénotypes potentiels de la dépendance alcoolique. Ceux-ci compren-
nent des phénotypes liés au métabolisme de l’alcool, à des mesures endocrines et physiologiques, à l’i-
magerie nerveuse, à l’électrophysiologie, à la personnalité, aux comportements vis-à-vis de la boisson et
aux réponses aux signaux alcooliques et dérivés de l’alcool. Cet article résume la littérature actuelle, mise
au point sur des données humaines, concernant des endophénotypes prometteurs dans l’analyse fine du
phénomène de l’alcoolisme.
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